Tolvaptan - Polycystic kidney disease
You are here : Home > Formulary Search > Tolvaptan - Polycystic kidney disease
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
NICE Technology Appraisal
Policy Statement
PAD Profile
ChemicalSubstance :
Tolvaptan
Indication :
Polycystic kidney disease
Group Name :
Keywords :
ADPKD
Brand Names Include :
Jinarc
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3
Other Indications
Below are listed other indications that Tolvaptan is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Polycystic kidney disease.
- No records returned.
Committee Recommendations (1)
The PCN supports the use of Tolvaptan for treating autosomal dominant polycystic kidney disease in line with NICE TA358 (October 2015)
Prescribing would be by nephrologists only, in line with NICE TA358 using the Blueteq initiation and continuation forms. Tolvaptan will be considered RED on the traffic light system
Prescribing would be by nephrologists only, in line with NICE TA358 using the Blueteq initiation and continuation forms. Tolvaptan will be considered RED on the traffic light system